Sorrento Therapeutics Names New CFO

San Diego-based Sorrento Therapeutics said today that it has named Kevin M. Herde as its new Executive Vice President and Chief Financial Officer. Herde was previously Vice President of Global Blood Screening and Alliance Management for Hologic, and also served at Gen-Probe, Gateway, and KPMG. Sorrento Therapeutics is a biopharmaceuticals firm developing treatments for cancer, inflammation and autoimmune diseases.